Cell Cycle Synchronization for iPSC Production Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methodologies for generating induced pluripotent stem cells (iPSCs) are inefficient due to the difficulty in isolating and synchronizing adult cells at specific cell cycle phases, which hampers their production for personalized and regenerative medicine applications.
Innovation Solution
The method involves synchronizing biological cells by arresting their cell cycles using conditions such as serum starvation, contact with cell cycle inhibiting agents, or low temperature, followed by selecting cells enriched in a specific cell cycle phase, and then transforming them using specific transformation agents like Oct family genes to generate iPSCs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cell cycle synchronization techniques are applied to improve iPSC production efficiency, then transformation efficiency increases, but process complexity and time requirements increase
Solution Approach 1:
The patent applies cell cycle synchronization techniques before the transformation step to ensure cells are in the optimal phase for transformation. This preliminary action of synchronizing cells at specific cycle stages (G1, S, G2, or M phase) using chemical agents or physical methods prepares the cell population in advance, thereby improving transformation efficiency and overall iPSC production efficiency.
Solution Approach 2:
The patent employs parameter changes by adjusting physical and chemical conditions (temperature, chemical agents, incubation times) to control and synchronize the cell cycle phases. By modifying these parameters, cells are directed to specific phases where they exhibit enhanced receptivity to transformation, thus improving iPSC generation efficiency.
2Productivity
If cell cycle synchronization is implemented to enhance transformation efficiency, then iPSC yield increases, but processing time increases
Solution Approach 1:
The patent utilizes periodic action through controlled incubation cycles with cell cycle synchronizing agents. Cells are exposed to synchronizing conditions for specific time periods, then released to progress through the cell cycle in a synchronized manner. This periodic approach allows efficient timing of transformation at optimal cell cycle phases, improving overall efficiency while managing processing time.
Solution Approach 2:
By synchronizing cells in advance before transformation, the patent ensures that the majority of cells are in the optimal phase for transformation when the procedure is performed. This preliminary synchronization reduces the need for repeated attempts or extended observation periods, thereby improving iPSC yield while controlling the additional time investment.
3Productivity
If multiple cell cycle phases are targeted to improve transformation efficiency, then iPSC production efficiency increases, but method complexity increases
Solution Approach 1:
The patent divides the cell population into different cell cycle phase groups and applies specific transformation protocols to each group. By segmenting the population based on cell cycle phase (G1, S, G2, or M phase), the method optimizes transformation conditions for each segment, thereby improving overall iPSC production efficiency while maintaining manageable complexity through systematic organization.
Solution Approach 2:
The patent applies different transformation conditions and parameters to cells in different cell cycle phases. Each phase-specific group receives tailored treatment optimized for its physiological state, such as specific chemical agents, incubation times, or physical conditions. This local quality approach maximizes transformation efficiency for each phase while maintaining overall method organization.
Data Source
AI summary
The techniques described herein provide for improved efficiency of iPSC production from biological cells. The approach achieves improved iPSC production efficiency by obtaining a set of cells whose cell cycles are synchronized at a specific, desired cell cycle phase, such as mitotic phase (also referred to as M phase). The efficacy with which such synchronized cells can be transformed into iPSCs is higher than for an arbitrary set of cells that comprises cells at a variety of different stages in their cycles. Accordingly, the approaches described herein allow efficient generation of iPSCs, thereby facilitating myriad technologies for personalized and regenerative medicine that rely upon the effective production of iPSCs.